Eric I Richman Gain Therapeutics, Inc. (GANX) insider trading activity

GANX Quotes by TradingView

Eric I Richman is Director of Gain Therapeutics, Inc.. Currently has a direct ownership of 272,629 shares of GANX, which is worth approximately $348,965. The most recent transaction as insider was on Sep 20, 2023, when has been sold 54,900 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 273K
0% 3M change
25.21% 12M change
Total Value Held $348,965

ERIC I RICHMAN Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 20 2023
BUY
Exercise of conversion of derivative security
-
54,900 Added 16.76%
272,629 Common Stock
May 25 2022
BUY
Open market or private purchase
$6,404 $2.58 p/Share
2,482 Added 1.13%
217,729 Common Stock
May 20 2022
BUY
Open market or private purchase
$26,194 $2.83 p/Share
9,256 Added 4.12%
215,247 Common Stock
May 19 2022
BUY
Open market or private purchase
$10,840 $2.71 p/Share
4,000 Added 1.9%
205,991 Common Stock
Aug 16 2021
BUY
Exercise of conversion of derivative security
$38,736 $7.87 p/Share
4,922 Added 2.22%
216,820 Common Stock

Also insider at

NBSE
NeuBase Therapeutics, Inc. Healthcare
Director
EIR

Eric I Richman

Director
Pittsburgh, PA

Track Institutional and Insider Activities on GANX

Follow Gain Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GANX shares.

Notify only if

Insider Trading

Get notified when an Gain Therapeutics, Inc. insider buys or sells GANX shares.

Notify only if

News

Receive news related to Gain Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on GANX